Novabiotics - a leading clinical-stage biotechnology company
Novabiotics about us Novabiotics clinical studies Novabiotics pipeline Novabiotics our news Novabiotics contact


Using immunology to transform life-threatening and life-limiting diseases

NovaBiotics’ proprietary technology platforms have been generated through rational drug design principles, using a ‘smart immunology’ approach.  These platforms are based on the body’s innate immune defense molecules, aminothiol and peptide first responders of the immune system to infectious and inflammatory challenge.  The therapy candidates we have developed from our platforms are ‘supercharged’ versions of these key molecules in combatting respiratory, inflammatory and infectious disease.


NovaBiotics’ have a number of publications across various platforms.  Please click on the link NovaBiotics publications to see the full list including links to view specific publications of interest.